IXC 0.00% 6.5¢ invex therapeutics ltd

Ann: Director Resignations and Appointment of Non-Executive Chair, page-16

  1. 17,489 Posts.
    lightbulb Created with Sketch. 416
    I unfortunately think that " big pharma" may not be interested or if they are it will be very lowball due to exenatides uncertainty.

    IXC is not negogiating from any position of strength.
    An ASX "shell" is worth something and one with cash .
    I wouldnt be surprised that a whole new direction is taken
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.